4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury

Kuang Ching Tseng, Haiyan Li, Andrew Clark, Leigh Sundem, Michael Zuscik, Mark Noble, John Elfar

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Traumatic peripheral nerve damage is a major medical problem without effective treatment options. In repurposing studies on 4-aminopyridine (4-AP), a potassium channel blocker that provides symptomatic relief in some chronic neurological afflictions, we discovered this agent offers significant promise as a small molecule regenerative agent for acute traumatic nerve injury. We found, in a mouse model of sciatic crush injury, that sustained early 4-AP administration increased the speed and extent of behavioral recovery too rapidly to be explained by axonal regeneration. Further studies demonstrated that 4-AP also enhanced recovery of nerve conduction velocity, promoted remyelination, and increased axonal area post-injury. We additionally found that 4-AP treatment enables distinction between incomplete and complete lesions more rapidly than existing approaches, thereby potentially addressing the critical challenge of more effectively distinguishing injured individuals who may require mutually exclusive treatment approaches. Thus, 4-AP singularly provides both a new potential therapy to promote durable recovery and remyelination in acute peripheral nerve injury and a means of identifying lesions in which this therapy would be most likely to be of value.

Original languageEnglish (US)
Pages (from-to)1409-1420
Number of pages12
JournalEMBO Molecular Medicine
Volume8
Issue number12
DOIs
StatePublished - Dec 1 2016

Fingerprint

Peripheral Nerve Injuries
4-Aminopyridine
Potassium Channel Blockers
Neural Conduction
Wounds and Injuries
Peripheral Nerves
Regeneration
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Medicine

Cite this

Tseng, Kuang Ching ; Li, Haiyan ; Clark, Andrew ; Sundem, Leigh ; Zuscik, Michael ; Noble, Mark ; Elfar, John. / 4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury. In: EMBO Molecular Medicine. 2016 ; Vol. 8, No. 12. pp. 1409-1420.
@article{f5357b8212f241f69317e83c9ddbb2ee,
title = "4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury",
abstract = "Traumatic peripheral nerve damage is a major medical problem without effective treatment options. In repurposing studies on 4-aminopyridine (4-AP), a potassium channel blocker that provides symptomatic relief in some chronic neurological afflictions, we discovered this agent offers significant promise as a small molecule regenerative agent for acute traumatic nerve injury. We found, in a mouse model of sciatic crush injury, that sustained early 4-AP administration increased the speed and extent of behavioral recovery too rapidly to be explained by axonal regeneration. Further studies demonstrated that 4-AP also enhanced recovery of nerve conduction velocity, promoted remyelination, and increased axonal area post-injury. We additionally found that 4-AP treatment enables distinction between incomplete and complete lesions more rapidly than existing approaches, thereby potentially addressing the critical challenge of more effectively distinguishing injured individuals who may require mutually exclusive treatment approaches. Thus, 4-AP singularly provides both a new potential therapy to promote durable recovery and remyelination in acute peripheral nerve injury and a means of identifying lesions in which this therapy would be most likely to be of value.",
author = "Tseng, {Kuang Ching} and Haiyan Li and Andrew Clark and Leigh Sundem and Michael Zuscik and Mark Noble and John Elfar",
year = "2016",
month = "12",
day = "1",
doi = "10.15252/emmm.201506035",
language = "English (US)",
volume = "8",
pages = "1409--1420",
journal = "EMBO Molecular Medicine",
issn = "1757-4676",
publisher = "Wiley-Blackwell",
number = "12",

}

4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury. / Tseng, Kuang Ching; Li, Haiyan; Clark, Andrew; Sundem, Leigh; Zuscik, Michael; Noble, Mark; Elfar, John.

In: EMBO Molecular Medicine, Vol. 8, No. 12, 01.12.2016, p. 1409-1420.

Research output: Contribution to journalArticle

TY - JOUR

T1 - 4-Aminopyridine promotes functional recovery and remyelination in acute peripheral nerve injury

AU - Tseng, Kuang Ching

AU - Li, Haiyan

AU - Clark, Andrew

AU - Sundem, Leigh

AU - Zuscik, Michael

AU - Noble, Mark

AU - Elfar, John

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Traumatic peripheral nerve damage is a major medical problem without effective treatment options. In repurposing studies on 4-aminopyridine (4-AP), a potassium channel blocker that provides symptomatic relief in some chronic neurological afflictions, we discovered this agent offers significant promise as a small molecule regenerative agent for acute traumatic nerve injury. We found, in a mouse model of sciatic crush injury, that sustained early 4-AP administration increased the speed and extent of behavioral recovery too rapidly to be explained by axonal regeneration. Further studies demonstrated that 4-AP also enhanced recovery of nerve conduction velocity, promoted remyelination, and increased axonal area post-injury. We additionally found that 4-AP treatment enables distinction between incomplete and complete lesions more rapidly than existing approaches, thereby potentially addressing the critical challenge of more effectively distinguishing injured individuals who may require mutually exclusive treatment approaches. Thus, 4-AP singularly provides both a new potential therapy to promote durable recovery and remyelination in acute peripheral nerve injury and a means of identifying lesions in which this therapy would be most likely to be of value.

AB - Traumatic peripheral nerve damage is a major medical problem without effective treatment options. In repurposing studies on 4-aminopyridine (4-AP), a potassium channel blocker that provides symptomatic relief in some chronic neurological afflictions, we discovered this agent offers significant promise as a small molecule regenerative agent for acute traumatic nerve injury. We found, in a mouse model of sciatic crush injury, that sustained early 4-AP administration increased the speed and extent of behavioral recovery too rapidly to be explained by axonal regeneration. Further studies demonstrated that 4-AP also enhanced recovery of nerve conduction velocity, promoted remyelination, and increased axonal area post-injury. We additionally found that 4-AP treatment enables distinction between incomplete and complete lesions more rapidly than existing approaches, thereby potentially addressing the critical challenge of more effectively distinguishing injured individuals who may require mutually exclusive treatment approaches. Thus, 4-AP singularly provides both a new potential therapy to promote durable recovery and remyelination in acute peripheral nerve injury and a means of identifying lesions in which this therapy would be most likely to be of value.

UR - http://www.scopus.com/inward/record.url?scp=84999885277&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84999885277&partnerID=8YFLogxK

U2 - 10.15252/emmm.201506035

DO - 10.15252/emmm.201506035

M3 - Article

C2 - 27861125

AN - SCOPUS:84999885277

VL - 8

SP - 1409

EP - 1420

JO - EMBO Molecular Medicine

JF - EMBO Molecular Medicine

SN - 1757-4676

IS - 12

ER -